Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID-19.

Autor: Saki N; Molecular Dermatology Research Center Shiraz University of Medical Sciences Shiraz Iran.; Department of Dermatology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Aslani FS; Molecular Dermatology Research Center Shiraz University of Medical Sciences Shiraz Iran.; Pathology Department Shiraz University of Medical Sciences Shiraz Iran., Sepaskhah M; Molecular Dermatology Research Center Shiraz University of Medical Sciences Shiraz Iran.; Department of Dermatology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Shafiei M; Department of Dermatology, Afzalipour Hospital, Afzalipour Faculty of Medicine Kerman University of Medical Sciences Kerman Iran., Alavizadeh S; Department of Dermatology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Hosseini SA; Postdoctoral Researcher Shiraz University of Medical Sciences Shiraz Iran., Asl FA; Department of Dermatology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Ahramiyanpour N; Department of Dermatology, Afzalipour Hospital, Afzalipour Faculty of Medicine Kerman University of Medical Sciences Kerman Iran.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2022 Aug 09; Vol. 10 (8), pp. e6228. Date of Electronic Publication: 2022 Aug 09 (Print Publication: 2022).
DOI: 10.1002/ccr3.6228
Abstrakt: Various conditions, including infections, can cause telogen effluvium (TE). One of them is coronavirus disease 2019 (COVID-19), where hair loss usually begins between 2 and 12 weeks after the illness. TE can be acute or chronic, and the chronic type can be intermittent. Here, we present the case of a 17-year-old girl with severe and widespread hair loss following an upper respiratory infection suspected to be COVID-19, with the patient having a history of such attacks since childhood. Evidence from biopsy and dermoscopy indicated a diagnosis of TE.
Competing Interests: The authors declare no conflicts of interest.
(© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: